Virtici LLC

Virtici LLC is a for-profit biomedical research and development company based in Seattle, Washington, specializing in advanced medical research across multiple therapeutic domains. The company focuses on developing innovative solutions in areas such as vaccines, diagnostics, therapeutics, and targeted molecular interventions, with a particular emphasis on addressing complex medical challenges. Registered in SAM.gov since September 2013, Virtici has established itself as a strategic research partner capable of conducting sophisticated scientific investigations for federal agencies.

Through its federal contract work, Virtici LLC has demonstrated expertise in developing advanced scientific solutions, particularly in vaccine and molecular research. The company's most notable federal contract was a $599,582 firm fixed price award from the National Institute of Allergy and Infectious Diseases (NIAID) to develop toll-like receptor agonists designed to strengthen sublingual vaccines. This contract was designated as a small business set-aside, highlighting Virtici's capability to compete effectively in specialized research domains. The contract focused on innovative vaccine enhancement techniques, showcasing the company's technical capabilities in immunological research and development.

Virtici LLC's federal grant portfolio reveals a robust research agenda targeting critical medical conditions across multiple domains. The company has secured several significant grants from agencies like the National Institute of Dental and Craniofacial Research and the National Institute on Aging, focusing on developing novel therapeutic and diagnostic interventions. Key research areas include developing inhibitors for periodontitis, creating blood-based diagnostics for neurodegenerative diseases like Alzheimer's and Frontotemporal Lobar Degeneration, and designing innovative treatments for conditions such as Neisseria gonorrhoeae infection. These grants, ranging from approximately $309,038 to $600,000, demonstrate Virtici's commitment to advancing medical science through targeted, innovative research strategies that address complex health challenges with potential broad societal impact.